Study

A clinical study (not to be confused with Research), either peer-reviewed or not, usually published on medical study outlets such as The Lancet, PubMed, or others.  Try to get the PDFs of these.

Covid-19 Vaccine Clinical Trials: Failure to Properly Assess Safety and Efficacy

by

November 2020 Safety When the Phase III trial for AstraZeneca and the University of Oxford’s COVID-19 vaccine was underway in England using another vaccine (Menveo) as a control (instead of a placebo), ICAN filed a forceful petition demanding that the FDA mandate that all clinical trials of COVID-19 vaccines use a placebo control as well as track … Read more

FDA Asks Court to Delay Full Release of Documents on Pfizer COVID Biologic for 55 Years

by
Source Link: https://thevaccinereaction.org/2021/11/fda-asks-court-for-55-years-to-fully-release-documents-on-pfizer-covid-biologic/ Excerpt:  In response to a Freedom of Information Act (FOIA) lawsuit filed on Sept. 16, 2021 against the U.S. Food and Drug Administration (FDA) by a medical transparency group of more than 30 physicians, professors and scientists from various universities in the United States, the FDA has asked a federal judge to ... Read more

Peter Doshi: COVID-19 Vaccine Trials Are NOT Designed to Tell Us What We Need To Know!

by

Presentation during a webinar with Peter Doshi, a scientist who focuses on the drug approval process and an award-winning health journalist. He warns that the COVID vaccines trials are NOT designed to show whether the vaccines reduce the risk of severe Covid-19, hospitalization, ICU use, or death, or whether they reduce spread of the disease. … Read more

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

by
Source Link: https://blogs.bmj.com/bmj/2020/11/26/peter-doshi-pfizer-and-modernas-95-effective-vaccines-lets-be-cautious-and-first-see-the-full-data/ Excerpt:  November 26, 2020 Only full transparency and rigorous scrutiny of the data will allow for informed decision making, argues Peter Doshi In the United States, all eyes are on Pfizer and Moderna. The topline efficacy results from their experimental covid-19 vaccine trials are astounding at first glance. Pfizer says it recorded ... Read more

These Coronavirus Trials Don’t Answer the One Question We Need to Know

by
Source Link: https://www.nytimes.com/2020/09/22/opinion/covid-vaccine-coronavirus.html Excerpt:  We may not find out whether the vaccines prevent moderate or severe cases of Covid-19. Sept. 22, 2020 By Peter Doshi and Eric Topol Dr. Doshi is an associate professor at the University of Maryland School of Pharmacy. Dr. Topol is a professor of molecular medicine at Scripps Research. If you ... Read more

ABSOLUTE (effectiveness) vs RELATIVE (efficacy) RISK REDUCTION in Research Reporting Bias

by

Doctors and the public are being told that these injections are “95% effective” but that is the intentional misrepresentation of 1) a STATISTICAL FINDING as if it were 2) REAL-WORLD PROTECTION Doctors and the general public are being told that these injections are “95% effective” but that is the intentional misrepresentation of 1) a statistical … Read more

How Effective Is The COVID-19 Vaccine?

by

“New details from the #Covid19 trials have revealed troubling details in the clinical trial design. This new revelation calls into question the real efficacy of the Covid vaccine.”  Credit to Del Bigtree and The Highwire: https://thehighwire.com/videos/how-effective-is-the-covid-19-vaccine/

People appear to die at rates 20 percent or more above normal for weeks after receiving their second Covid vaccine dose, according to data from a huge Swedish study

by

Another major red flag about Covid vaccines and death This one coming from data on more than 4 million vaccinated Swedes Alex Berenson Nov 18 898 408 People appear to die at rates 20 percent or more above normal for weeks after receiving their second Covid vaccine dose, according to data from a huge Swedish … Read more